Almeida Madson Q, Brito Luciana Pinto, Domenice Sorahia, Costa Marcia Helena Soares, Pinto Emilia Modolo, Osório Cynthia A Toledo, Latronico Ana Claudia, Mendonca Berenice B, Fragoso Maria Candida B V
Hospital das Clínicas, Universidade de São Paulo, SP, Brasil.
Arq Bras Endocrinol Metabol. 2008 Nov;52(8):1257-63. doi: 10.1590/s0004-27302008000800009.
Primary pigmented nodular adrenocortical disease (PPNAD) is the main endocrine manifestation of Carney complex, a multiple neoplasia syndrome caused by PRKAR1A gene mutations. The presence of PRKAR1A loss of heterozygosity (LOH) in adrenocortical tumorigenesis remains controversial. The aim of the present study is to investigate the presence of PRKAR1A LOH in adrenocortical cells in a patient with Carney complex.
The LOH was investigated using a PRKAR1A informative intragenic marker by GeneScan software analysis in DNA obtained from laser-captured microdissected cells of several adrenal nodules.
A young adult male patient with Carney complex and his family were studied.
A novel heterozygous mutation (p. Y21X) was identified at PRKAR1A in blood DNA of the male proband and his relatives. No PRKAR1A LOH was evidenced in the laser-captured microdissected cells from PPNAD tissue by different methodologies.
We identified a new PRKAR1A nonsense mutation and in addition we did not evidence PRKAR1A LOH in laser-captured nodules cells, suggesting that adrenocortical tumorigenesis in PPNAD may occurs apart from the second hit.
原发性色素沉着性结节性肾上腺皮质疾病(PPNAD)是卡尼综合征的主要内分泌表现,卡尼综合征是一种由PRKAR1A基因突变引起的多发性肿瘤综合征。PRKAR1A杂合性缺失(LOH)在肾上腺皮质肿瘤发生中的存在仍存在争议。本研究的目的是调查一名卡尼综合征患者肾上腺皮质细胞中PRKAR1A LOH的存在情况。
使用PRKAR1A基因内信息性标记,通过基因扫描软件分析,对从多个肾上腺结节的激光捕获显微切割细胞中获得的DNA进行LOH检测。
研究了一名患有卡尼综合征的年轻成年男性患者及其家族。
在男性先证者及其亲属的血液DNA中,PRKAR1A基因发现了一个新的杂合突变(p.Y21X)。通过不同方法,在PPNAD组织的激光捕获显微切割细胞中未发现PRKAR1A LOH。
我们鉴定出一个新的PRKAR1A无义突变,此外,在激光捕获的结节细胞中未发现PRKAR1A LOH,这表明PPNAD中的肾上腺皮质肿瘤发生可能与第二次打击无关。